Actinium Pharmaceuticals Inc. (Delaware)

(ATNM)

By |

Profile

Actinium Pharmaceuticals Inc is a biopharmaceutical company engaged in the development of innovative-targeted therapies for patients with cancers lacking effective treatment options. The company's proprietary technology platform utilizes monoclonal antibodies to deliver radioisotopes directly to cells of interest in order to kill those cells safely and effectively. Its most advanced products are Iomab-B, an antibody-drug construct containing iodine 131 (I-131), used in myeloconditioning for hematopoietic stem cells transplantation in various indications and Actimab-A, an antibody-drug construct containing actinium 225 (Ac-225), currently in human clinical trials for acute myeloid leukemia.

Contact Information

Website: www.actiniumpharma.com
Email: investorrelations@actiniumpharma.com
Main Phone: +1 646 677-3870
Address: 275 Madison Avenue
Address 2: 7th Floor
State: NY
City / Town: New York
Country: USA
Postal Code: 10016

Issuer Information

Exchange: AMX
CEO: Sandesh Seth
Employees: 25
NAICS: Pharmaceutical Preparation Manufacturing(325412)
$ 0.42 $ 0.0022 (0.53%)
Last Price 0.42 Change $ 0.0022 Change % 0.53 Tick N/A
Bid 0.42 Bid Size 1,400.00 Ask 0.43 Ask Size 5,200.00
Open 0.42 High 0.42 Low 0.42 Prev Close 0.42
Last Trade Volume 20,703 52 Wk Hi 0.87 52 Wk Low 0.33
Market Cap 48.6 mi Ex-Div Date N/A Div Rate N/A Yield N/A
Shares 115,698,044.00 EPS (TTM) -0.23 PE Ratio N/A Exchange NYSE American
  Last 3 Mo Last 12 Mo
Number of Insider Trades 1 9
Number of Buys 1 9
Number of Sells 0 0
Net Activity 5000 164563
Last 10 Buys Shares
Sandesh Seth 1,000
Ajit S. Shetty 1,000
Sandesh Seth 1,000
Nitya G. Ray 1,000
Sandesh Seth 1,000
Sandesh Seth 1,000
Steven O'Loughlin 1,000
Mark S. Berger 1,000
Sandesh Seth 1,000
Sandesh Seth 1,000
Last 10 Sell Shares
N/A 0
  Current 1 Week Ago 2 Weeks Ago 3 Weeks Ago
High Target Price Estimate 6 6 6 8
Low Target Price Estimate 2.75 2.75 2.75 2.75
Mean Target Price Estimate 4.19 4.19 3.92 4.95
Standard Deviation 1.57 1.57 1.81 2.18
Date of Most Recent Estimate 05/31/18 05/29/18 05/23/18 05/31/18
  Current 1 Month Ago 2 Months Ago 3 Months Ago
Strong Buy 5 4 3 3
Moderate Buy 0 0 0 0
Hold 0 0 0 0
Moderate Sell 0 0 0 0
Strong Sell 0 0 0 0
Mean Rec. 1 1 1 1